Image 1
The given text is not-available.*
Torsemide Tablet
Product Images NDC 50111-918
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Torsemide (NDC 50111-918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a description of a medication with the NDC code 50111-915-01. The medication is torsemide, provided in tablets of 9mg with each containing 5mg of torsemide USP. The recommended dosage is available in the package insert. It is advised to keep the medication in a tightly-sealed, light-resistant container away from children, and store it at a temperature between 20°C to 25°C. The manufacturer of the medication is Pliva Hrvatska, d.o.o. located in Zagreb, Croatia. The medication is produced for Teva Pharmaceuticals USA Inc., located in North Wales, PA. The description contains information about the container, dosage, and storage of medication.*
Image 3
This is a drug called Torsemide in the form of tablets, with each tablet containing 10mg of the drug. The appropriate dosage should be obtained through referring to the package insert or as directed by a healthcare professional. The drug should be stored within a temperature range of 20° to 25°C (68° to 77°F) and in a sealed container that is light-resistant and has child-resistant closure. The drug is manufactured in Croatia by Pliva Hrvatska d.o.0, and distributed in North Wales, PA by Teva Pharmaceuticals USA, Inc.*
Image 4
This is a description of Torsemide tablets with a concentration of 20 mg, which are prescribed for the treatment of fluid retention (edema) in people with congestive heart failure, liver disease, or kidney disease. The text provides details on the manufacturer, dosage, and storage requirements of the medication. It also includes a caution to keep the medication out of reach of children.*
Image 5
This is a description of Torsemide tablets containing 100mg active ingredient per tablet. The package contains 100 tablets and should be stored in a controlled room temperature as stated in USP. The medicine should be kept in a tight container and out of reach of children. The prescription information is in the package insert. The tablets are manufactured by Pliva Hrvatska in Zagreb, Croatia, and distributed by Teva Pharmaceuticals USA in North Wales, PA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
